HKUCTR-2798
Untitled Trial
A Phase 2, Single Arm, Multi-center, Open-Label Trial to Evaluate the Safety and Efficacy of Treatment with Tumor Treating Fields (TTFields) and Chemotherapy as First-Line Treatment for Subjects with Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Gastric (GC) Adenocarcinoma.
Novocure GmbH·Phase 2·HKU CLINICAL TRIALS REGISTRY·device·Device trialCompleted
Study focus
- Disease/Condition
- Neoplasm
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Novocure GmbH
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- Dec 31, 2021
ICD-10 classifications
NeoplasmsBenign neoplasmsIn situ neoplasmsPersonal history of other neoplasmsBenign neoplasm: Other specified sites
Data source
- Registry
- HKU CLINICAL TRIALS REGISTRY
- Trial ID
- HKUCTR-2798
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for HKUCTR-2798 through Pure Global AI's free database. This Phase 2 trial is sponsored by Novocure GmbH and is currently Completed. The study focuses on Neoplasm.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to HKU CLINICAL TRIALS REGISTRY data, helping medical device and pharmaceutical companies navigate clinical research efficiently.